# Study on the Relationship Between Asymmetric Vascular Sign of Cortex and Prognosis in Massive Cerebral Infarction

Study · id `cardio:ct-nct04247659` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04247659](<https://clinicaltrials.gov/study/NCT04247659>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04247659

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT04247659. Randomized; single masking; primary purpose prevention. Start 2020-01-09 (actual); primary completion 2021-06-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT04247659, source copy `cardio:ctgov-nct04247659-2020-01-30`, retrieved 2026-10-26)
- Started: 2020-01-09 (actual) (ClinicalTrials.gov record NCT04247659, source copy `cardio:ctgov-nct04247659-2020-01-30`, retrieved 2026-10-26)
- Primary completion: 2021-06-09 (anticipated) (ClinicalTrials.gov record NCT04247659, source copy `cardio:ctgov-nct04247659-2020-01-30`, retrieved 2026-10-26)
- Completion: 2021-09-09 (anticipated) (ClinicalTrials.gov record NCT04247659, source copy `cardio:ctgov-nct04247659-2020-01-30`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04247659, source copy `cardio:ctgov-nct04247659-2020-01-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04247659-2020-01-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study on the Relationship Between Asymmetric Vascular Sign of Cortex and Prognosis in Massive Cerebral Infarction
- Condition: Cerebral Infarction
- Condition: Cerebral Edema
- Intervention (Drug): sodium aescinate
- Lead sponsor: The Second Hospital of Hebei Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: The Second Hospital of Hebei Medical University (`cardio:org-the-second-hospital-of-hebei-medical-university`)

## Provenance

Content hash: a21a29a45e67ee44dc93a4fc1628d1e977fdfb540931b7d11461f6a8188bf18b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
